Cell therapy weekly: Regulators approve autologous stem cell therapy for spinal cord injury in Japanese first
Cell therapy weekly: £1.1million funding for new research into patient experience of cell therapy
The Regenerative Medicine Resource Center: supporting preclinical interdisciplinary dental, oral and craniofacial projects
Cell therapy weekly: Positive outlook for oncology patients receiving immunotherapies
Cell therapy weekly: CCRM and GE Healthcare to assist in scale-up of degenerative disc disease therapy
Cell therapy weekly: Novo Nordisk continues to investigate stem cell therapies for chronic diseases and Kite expands manufacturing capability
In this interview, filmed at the World Advanced Therapies and Regenerative Medicine Congress (16–18 May, London, UK), Simon Ellison, World Courier, explains more about the importance of considering the supply chain in the advanced therapy development process.